Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peritoneal dialysis in the next millennium.

D G Oreopoulos1, A H Tzamaloukas

  • 1Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Advances in Renal Replacement Therapy
|November 10, 2000
PubMed
Summary

Preventing end-stage renal disease (ESRD) is crucial. Peritoneal dialysis (PD) offers a successful, cost-effective treatment option with potential for future advancements in patient care and outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blood pressure control and kidney damage in hypertension: Results of a three-center cross-sectional study in North Central Nigeria.

Nigerian journal of clinical practice·2020
Same author

Association between scleroderma, renal cell carcinoma and membranous nephropathy.

Clinical nephrology·2009
Same author

Interleukin-6 modulates hepatic and muscle protein synthesis during hemodialysis.

Kidney international·2008
Same author

Haemodialysis induces mitochondrial dysfunction and apoptosis.

European journal of clinical investigation·2007
Same author

Inadequacy of dialysis, chronic inflammation and malnutrition in Nigerian patients on chronic hemodialysis.

The International journal of artificial organs·2006
Same author

Use of the adjective 'membranous' to categorize hemodiafiltration and hemofiltration.

The International journal of artificial organs·2006

Area of Science:

  • Nephrology
  • Renal Disease Research
  • Dialysis Technology

Background:

  • End-stage renal disease (ESRD) presents a growing epidemic, necessitating improved treatment strategies.
  • While xenotransplantation and stem cell therapies are future possibilities, dialysis remains the primary treatment for increasing ESRD patient numbers.
  • Peritoneal dialysis (PD) has demonstrated significant success, particularly in pediatric cases, with low peritonitis rates and comparable or superior survival to hemodialysis.

Purpose of the Study:

  • To outline future improvements in peritoneal dialysis (PD) to enhance its efficacy and patient outcomes.
  • To address the increasing prevalence of ESRD by optimizing PD as a primary treatment modality.
  • To identify key areas for advancement in PD to reduce technique failure and improve long-term patient management.

Main Methods:

  • The report presents expert views and projections on the future of PD.
  • It focuses on identifying areas for improvement in PD technology and patient care.
  • Discussion includes advancements in solutions, access devices, and nutritional support.

Main Results:

  • PD is the preferred treatment for children and effective for those awaiting transplantation.
  • Automated PD ensures adequate clearances, and PD offers lower costs with good survival rates.
  • Future improvements aim to reduce technique failure, protect the peritoneal membrane, prevent malnutrition, and enhance access devices.

Conclusions:

  • Peritoneal dialysis (PD) is a vital treatment for end-stage renal disease (ESRD) with significant advantages.
  • Further advancements in PD are expected to increase its long-term viability and patient acceptance.
  • The goal is to establish PD as the first-choice treatment for the majority of ESRD patients.

Related Experiment Videos